6 stocks that kept FTSE 100 above 7,200 this week

The FTSE 100 index continued to remain above 7,200 during the week, as companies reported positive developments. However, there were drags too.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

At the end of last week, the FTSE 100 index closed at highs not seen since February 2020, before the pandemic started. Just for this reason, I was cautious of what this week would bring. Going by the recent fluctuations in stock markets, I was braced for yet another correction. But the index has stood its ground. 

Improving trends for the FTSE 100 index

For four of the five trading sessions this week, the FTSE 100 index closed higher than 7,200, ending the week at 7,204.5. It closed below the level on Thursday but only just, at 7,190. As a result, the average index level in October is now 1% higher than it was during the month before. This is encouraging in any case, but particularly so because the month started on a poor note. And this followed a 1% fall in the index in September from the month before. 

AstraZeneca advances, UBS raises target price

Now, of course the general investor mood has shifted for the better as some stocks performed well. One of them was the pharmaceutical giant AstraZeneca, whose share price crossed 9,000p for the first time since July last year. This brings it much closer to the all-time highs of 9,320p touched then. The increase follows positive results from the trials of its liver cancer drug. Investment firm UBS raised its price target for the company to 10,000 from 9,200 earlier, which may have increased investor enthusiasm for the stock too.  

Burberry appoints new CEO

Luxury brand and retailer Burberry was another news-making stock, and also showed moderate gains this week. It said that Jonathan Akeroyd, who is currently CEO of Versace, will now be heading it. Its former CEO, Marco Gobbetti, who is credited for the company’s strong performance over the past few years, had put in his papers recently. 

Positive results’ season

Engineering company Renishaw was a big gainer this week. The company’s annual revenue grew by 11% for the year ending 30 June from the year before. And its adjusted pre-tax profits grew by a whole 146%. The stock gained around 10% this week. Analytics provider Relx also showed small gains after it upgraded its outlook due to increased demand for analytics. Chemicals company Croda International also rallied on good results.

Unilever, the fast-moving consumer goods multinational, also inched up a bit after it reported higher than expected underlying sales in the third quarter compared to the year before. The number stood at 2.5% compared to expectations of 2.2%. However, cost pressures are taking their toll on the company, which warned of price increases in the future. 

Inflation drag on the FTSE 100 index

In fact, inflation may have been one of the drags on the index, holding it back from further progress. Earlier this week, it came in above 3% for the second month running in September even as the economic recovery remains weak. While companies’ results are heartening this week, going by the latest price increases, I think more companies will allude to rising costs in the results expected next week as well. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Manika Premsingh owns shares of AstraZeneca and Burberry. The Motley Fool UK has recommended Burberry, Croda International, RELX, Renishaw, and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »